Additionally, when CD4+ T cells from study subjects were stimulated with anti-CD3+ rIL-2, CD4+ T cells from SPMS patients were unable to induce normal surface CTLA-4 expression, and even among RRMS patients, its expression was decreased [154]. This evidence concerns the gene CD4 and relapsing-remitting multiple sclerosis.